Skip to main content
Clinical Trials/NCT02998684
NCT02998684
Completed
N/A

Learning Enhancement Through Neurostimulation in Autism

Medical University of South Carolina1 site in 1 country25 target enrollmentJuly 2016
ConditionsAutism

Overview

Phase
N/A
Intervention
Not specified
Conditions
Autism
Sponsor
Medical University of South Carolina
Enrollment
25
Locations
1
Primary Endpoint
Test of Adolescent Social Skills Knowledge (TASSK)
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

This study will examine whether brain stimulation paired with social skills learning can help teenage boys with autism learn how to make and keep friends. Brain stimulation can enhance learning in some people. This study involves enrolling in a 14-week training program where teenage boys with autism interact in small groups and learn social skills. During the 14-week program participants will receive active brain stimulation, or non-active stimulation (placebo). Before and after this training, MRI scans will be taken to see whether the training with active brain stimulation made a different in brain activation.

Registry
clinicaltrials.gov
Start Date
July 2016
End Date
July 2017
Last Updated
7 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Autism Spectrum Disorder

Exclusion Criteria

  • Intellectual Disabilities (Full-scale IQ \<70)
  • Hx of seizures within the last one year
  • Contraindications for fMRI, such as metal implants in the head

Outcomes

Primary Outcomes

Test of Adolescent Social Skills Knowledge (TASSK)

Time Frame: Baseline to 14-weeks

Change in TASSK raw scores from pre- to post-treatment, i.e., baseline to 14-weeks (Post minus pre-treatment: positive scores indicate improvement). Assessment scores can range from 0 to 26, 0 being the lowest possible score and 26 being the highest.

Social Responsiveness Scale (SRS)

Time Frame: Baseline to 14 weeks

Change in SRS raw scores from pre- to post-treatment, i.e., baseline to 14-weeks (Pre minus post-treatment: positive scores indicate improvement). Raw scores range from 0 to 195, with higher scores indicating greater severity of symptoms.

Study Sites (1)

Loading locations...

Similar Trials